The Canada nuclear medicine market size was valued at USD 414.31 million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 15.16% from 2024 to 2030. The growth of Canada’s nuclear medicine market is attributed to the increasing demand for early & accur... Read More »
December 2023The global urinalysis market size was valued at USD 2.14 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030. The market is witnessing growth due to factors including the rising incidence of diseases such as Urinary Tract Infecti... Read More »
December 2023The global central lab market size was valued at USD 3.28 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.44% from 2024 to 2030. The growth can be attributed to increasing investment in R&D and increased focus of sponsors & investigators on r... Read More »
December 2023The global liquid biopsy market size was estimated at USD 10.42 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.60% from 2024 to 2030. The market for liquid biopsy is witnessing growth due to factors such as the growing prevalence of cancer, technol... Read More »
December 2023The global breast cancer core needle biopsy market was valued at USD 776.97 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2030. The market is rapidly expanding, driven by factors such as the increasing prevalence of breast malignanci... Read More »
December 2023The Europe in vitro diagnostics market size was valued at USD 28.98 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 0.7 % from 2023 to 2030.The growing base of the geriatric population in European countries, the increasing prevalence of chronic disea... Read More »
December 2023The global qPCR instruments market size was valued at USD 1.0 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030. The growing prevalence of diseases, technological advancements, and increasing demand for qPCR ins... Read More »
December 2023The global liver disease diagnostics market size was valued at USD 35.37 billion in 2022 and is anticipated to grow at a CAGR of 6.5% from 2023 to 2030. One of the key factors anticipated to propel the market for liver disease diagnostics is the increasing number of acute and chronic liv... Read More »
November 2023The global cancer diagnostics market size was estimated at USD 107.45 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.16% from 2024 to 2030. The growth of this industry is attributed to the growing prevalence of cancer, technological advancements in d... Read More »
November 2023The U.S. influenza diagnostics market size was valued at USD 179.9 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030. The recurring seasonal outbreaks of influenza act as a key driving force for the market. Increased awareness am... Read More »
November 2023The Europe molecular diagnostics market size was valued at USD 8.37 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030. As a developed region, technology enhancement is enabling the European market to grow further by developing ne... Read More »
November 2023The global primary care POC diagnostics market size was valued at USD 15.40 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030. The rapid evolution of point-of-care testing (POCT) holds enormous potential for the growth of both pr... Read More »
October 2023The global urinary tract infection testing market size was valued at USD 579.2 million in 2022 and is anticipated to grow at a CAGR of 4.4% from 2023 to 2030 owing to factors such as the rising incidence rate of urinary tract infections., rapid technological advancements, increasing geri... Read More »
October 2023The Latin America flow cytometry market size was estimated at USD 337.60 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.44% from 2023 to 2030. The Latin America flow cytometry industry is witnessing growth due to rising R&D initiatives in clini... Read More »
October 2023The global bloodstream infection testing market was valued at USD 689.13 million in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2030. Bloodstream infection testing is crucial in identifying the bacteria and other pathogens responsible for bl... Read More »
October 2023The U.S. burn care centers market size was estimated at USD 7.72 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.66% from 2023 to 2030. The growing cases of burn-related Emergency Department (ED) visits and increasing admissions of patients in hospita... Read More »
October 2023The Asia Pacific point of care diagnostics market was valued at USD 8.17 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2023 to 2030. The Asia Pacific region has seen significant growth in the point-of-care diagnostics market owing to factors... Read More »
October 2023The global cardiac biomarkers market size was valued at USD 16.05 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2030. Cardiac biomarkers are witnessing growth owing to factors such as the high prevalence of acute coronary syndrom... Read More »
October 2023The global comprehensive metabolic panel testing market size was estimated at USD 10.19 billion in 2022 and is expected to grow a compound annual growth rate (CAGR) of 9.1% from 2023 to 2030. Factors such as the rising prevalence of chronic diseases and emphasis on early diagnosis and tr... Read More »
October 2023The global oncology companion diagnostic market size was valued at USD 3.1 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.9 from 2023 to 2030. The evolving role of oncology companion diagnostics in the era of next-generation omics is expected to dri... Read More »
September 2023